Biotech

All Articles

Ideaya bags possibility on Biocytogen bispecific ADC in $400M deal

.Ideaya Biosciences is actually wagering $400 thousand in biobucks that a bispecific antibody-drug c...

Takeda takes $140M loss on neglected epilepsy drug, proclaims FDA manage

.We actually understand that Takeda is actually intending to find a course to the FDA for epilepsy m...

VBI Vaccines declare bankruptcy, finds asset purchase

.Immunology biotech VBI Vaccines is actually veering alarmingly close to the point of no return, wit...

Celldex anti-cKIT antibody lower colonies in another phase 2 research

.It is actually difficult to muscular tissue in on a room as competitive as immunology, however Cell...

Boehringer provides to $1.3 B for gate prevention biotech

.Boehringer Ingelheim is actually offering up to $1.3 billion for Nerio Therapies and a preclinical ...

Ventyx's last hope for inflammatory med sides in Crohn's breakdown

.Ventyx Biosciences' Crohn's condition medicine did certainly not aid people attain remission in a s...

Cognition's period 2 SHINE data taint Alzheimer's possibility

.Knowledge Rehabs' stage 2 SHINE test has taken some of the gloss off the Alzheimer's disease medica...

BMS axes bispecific months after submitting to work period 3 trial

.Bristol Myers Squibb has possessed a whiplash change of mind on its own BCMA bispecific T-cell enga...

Charles Baum takes over Terremoto as chief executive officer

.Charles Baum, M.D., Ph.D., that managed Mirati Therapeutics' $ 5.8 billion purchase to Bristol Myer...

Asarina to shut after initiatives to partner Tourette's medicine stop working

.After communicating to much more than 200 providers to companion a Tourette disorder treatment that...